The following is a summary of “Longitudinal assessment of immunoglobulin response and disease progression in critically ill ...

“The cumulative incidence of non-relapse mortality [14% at 3 years] reflects how heavily pretreated this cohort was,” Dr Kramer said. Immunoglobulin G replacement therapy was “essential” for most ...

Hansa Biopharma has developed a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients. Hansa ...

Genethon & Hansa begin phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome: Lund, Sweden Wednesday, December 4, 2024, 18:00 Hrs [IST] Hans ...

Søren Tulstrup, President and CEO, Hansa Biopharma said, “We know that anti-AAV antibodies prevent up to 1 in 3 people from benefitting from gene therapies using AAV-vectors. 1-4 That’s why our ...

Biohaven's pipeline includes Troriluzole for SCA, BHV-2100 for migraines, and Taldefgrobep Alfa for SMA. See why BHVN stock ...

ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ...

AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ALYGLO™, an FDA-approved ...

Observational studies have identified a link between immunoglobulin G (IgG) N-glycosylation and various psychiatric conditions, but the causality of these associations remains unclear. Methods: ...

Therapy may be a successful strategy to help you cope with stress. Types of therapies for stress and other conditions include cognitive behavioral therapy, exposure therapy, psychodynamic therapy ...

"Machine learning is a very helpful tool when examining the use of nanoparticles in diagnostics and therapy applications in the field of nanomedicine. This will be one the main goals in our next ...